Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery

AD is a chronic neurodegenerative disease. Many different signaling pathways, such as Wnt/β-catenin, Notch, ROS/JNK, and PI3K/Akt/mTOR are involved in Alzheimer’s disease and crosstalk between themselves. A promising treatment involves the uses of flavonoids, and one of the most promising is curcumi...

Full description

Bibliographic Details
Main Author: Duygu Ege
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Materials
Subjects:
Online Access:https://www.mdpi.com/1996-1944/14/12/3332
_version_ 1797529934321680384
author Duygu Ege
author_facet Duygu Ege
author_sort Duygu Ege
collection DOAJ
description AD is a chronic neurodegenerative disease. Many different signaling pathways, such as Wnt/β-catenin, Notch, ROS/JNK, and PI3K/Akt/mTOR are involved in Alzheimer’s disease and crosstalk between themselves. A promising treatment involves the uses of flavonoids, and one of the most promising is curcumin; however, because it has difficulty permeating the blood–brain barrier (BBB), it must be encapsulated by a drug carrier. Some of the most frequently studied are lipid nanocarriers, liposomes, micelles and PLGA. These carriers are further conjugated with brain-targeting agents such as lactoferrin and transferrin. In this review paper, curcumin and its therapeutic effects, which have been examined in vivo, are analyzed and then the delivery systems to the brain are addressed. Overall, the analysis of the literature revealed great potential for curcumin in treating AD and indicated the challenges that require further research.
first_indexed 2024-03-10T10:21:57Z
format Article
id doaj.art-e7858e64329247a195ad92be326d66d1
institution Directory Open Access Journal
issn 1996-1944
language English
last_indexed 2024-03-10T10:21:57Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series Materials
spelling doaj.art-e7858e64329247a195ad92be326d66d12023-11-22T00:23:57ZengMDPI AGMaterials1996-19442021-06-011412333210.3390/ma14123332Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted DeliveryDuygu Ege0Biomedical Engineering, Boğaziçi University, Rasathane Cd, Kandilli Campus, Istanbul 34684, TurkeyAD is a chronic neurodegenerative disease. Many different signaling pathways, such as Wnt/β-catenin, Notch, ROS/JNK, and PI3K/Akt/mTOR are involved in Alzheimer’s disease and crosstalk between themselves. A promising treatment involves the uses of flavonoids, and one of the most promising is curcumin; however, because it has difficulty permeating the blood–brain barrier (BBB), it must be encapsulated by a drug carrier. Some of the most frequently studied are lipid nanocarriers, liposomes, micelles and PLGA. These carriers are further conjugated with brain-targeting agents such as lactoferrin and transferrin. In this review paper, curcumin and its therapeutic effects, which have been examined in vivo, are analyzed and then the delivery systems to the brain are addressed. Overall, the analysis of the literature revealed great potential for curcumin in treating AD and indicated the challenges that require further research.https://www.mdpi.com/1996-1944/14/12/3332ADcurcuminlipid-based carriersPLGAin vivodrug delivery
spellingShingle Duygu Ege
Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery
Materials
AD
curcumin
lipid-based carriers
PLGA
in vivo
drug delivery
title Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery
title_full Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery
title_fullStr Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery
title_full_unstemmed Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery
title_short Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery
title_sort action mechanisms of curcumin in alzheimer s disease and its brain targeted delivery
topic AD
curcumin
lipid-based carriers
PLGA
in vivo
drug delivery
url https://www.mdpi.com/1996-1944/14/12/3332
work_keys_str_mv AT duyguege actionmechanismsofcurcumininalzheimersdiseaseanditsbraintargeteddelivery